Literature DB >> 8491086

Expression of corticotropin-releasing factor mRNA in response to stress.

S L Lightman1, M S Harbuz.   

Abstract

The corticotropin-releasing factor (CRF)-containing neurons of the parvocellular division of the hypothalamic paraventricular nucleus play a pivotal role in the regulation of the hypothalamo-pituitary-adrenal axis. We have studied the regulation of these neurons in the conscious rat using the technique of quantitative in situ hybridization histochemistry. Corticosteroid feedback reduces CRF mRNA levels in a dose-dependent manner, although even prolonged administration of very high doses cannot abolish CRF transcripts completely. Both physical and psychological stressors produce a robust and readily reproducible increase in CRF mRNA. These responses cannot be prevented by changes in circulating corticosteroids--a similar magnitude of response occurs with high basal levels in the adrenalectomized animal and with low basal levels during treatment with supraphysiological doses of glucocorticoid. Alterations in CRF mRNA levels in response to stress are, however, lost during the physiological condition of lactation, a state known to result in stress hyporesponsiveness, and also after 6-hydroxydopamine lesions to the catecholaminergic innervation of the paraventricular nucleus. We have also studied two conditions of chronic immunological activation of the hypothalamo-pituitary-adrenal axis--adjuvant-induced arthritis and experimental allergic encephalomyelitis. Both of these results in activation of the hypothalamo-pituitary-adrenal axis with increased plasma corticosterone and ACTH, and pituitary pro-opiomelanocortin (POMC) mRNA. Unexpectedly, however, the activation of pituitary corticotrophs does not seem to be a primary result of increased activation of the CRF neurons, which actually show a consistent fall in CRF mRNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491086     DOI: 10.1002/9780470514368.ch9

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  19 in total

1.  Co-localization of corticotropin-releasing hormone with glutamate decarboxylase and calcium-binding proteins in infant rat neocortical interneurons.

Authors:  X X Yan; T Z Baram; A Gerth; L Schultz; C E Ribak
Journal:  Exp Brain Res       Date:  1998-12       Impact factor: 1.972

2.  Infantile spasms: hypothesis-driven therapy and pilot human infant experiments using corticotropin-releasing hormone receptor antagonists.

Authors:  T Z Baram; W G Mitchell; K Brunson; E Haden
Journal:  Dev Neurosci       Date:  1999-11       Impact factor: 2.984

3.  Chronic combined stress induces selective and long-lasting inflammatory response evoked by changes in corticosterone accumulation and signaling in rat hippocampus.

Authors:  Aleksey Piskunov; Mikhail Stepanichev; Anna Tishkina; Margarita Novikova; Irina Levshina; Natalia Gulyaeva
Journal:  Metab Brain Dis       Date:  2016-01-18       Impact factor: 3.584

4.  Development neurobiology of the stress response: multilevel regulation of corticotropin-releasing hormone function.

Authors:  T Z Baram; S Yi; S Avishai-Eliner; L Schultz
Journal:  Ann N Y Acad Sci       Date:  1997-04-24       Impact factor: 5.691

5.  Maternal deprivation effect on the infant's neural stress markers is reversed by tactile stimulation and feeding but not by suppressing corticosterone.

Authors:  H J van Oers; E R de Kloet; T Whelan; S Levine
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

6.  Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization.

Authors:  T Z Baram; C E Ribak
Journal:  Neuroreport       Date:  1995-01-26       Impact factor: 1.837

7.  Corticosterone influences on Mammalian neonatal sensitive-period learning.

Authors:  Stephanie Moriceau; Regina M Sullivan
Journal:  Behav Neurosci       Date:  2004-04       Impact factor: 1.912

Review 8.  The central corticotropin releasing factor system during development and adulthood.

Authors:  Aniko Korosi; Tallie Z Baram
Journal:  Eur J Pharmacol       Date:  2008-01-19       Impact factor: 4.432

9.  Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis.

Authors:  H S Chowdrey; P J Larsen; M S Harbuz; D S Jessop; G Aguilera; D J Eckland; S L Lightman
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

10.  Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat.

Authors:  C G Hatalski; C Guirguis; T Z Baram
Journal:  J Neuroendocrinol       Date:  1998-09       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.